Adenovirus Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

Adenovirus Vaccine Trends and Forecast

The future of the global adenovirus vaccine market looks promising with opportunities in the research and academic, laboratories, and pharmaceutical & biotechnology markets. The global adenovirus vaccine market is expected to reach an estimated $1.4 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are the rapidly increasing need for vaccinations in cancer gene therapies and surge in vaccination demand from pharmaceutical companies.

A more than 150-page report is developed to help in your business decisions.

Adenovirus Vaccine by Segment

The study includes a forecast for the global adenovirus vaccine by type, application, and region.

Adenovirus Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Type 4 Vaccine
• Type 7 Vaccine

Adenovirus Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Research and Academic
• Laboratories
• Pharmaceutical & Biotechnology

Adenovirus Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Adenovirus Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies adenovirus vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the adenovirus vaccine companies profiled in this report include-

• Novasep
• Charles River Laboratories
• Uniqure
• Waisman Biomanufacturing
• Creative-Biogene
• Aldevron
• Addgene
• Thermo Fisher Scientific
• Fujifilm Corporation
• Spark Therapeutics

Adenovirus Vaccine Market Insights

Lucintel forecasts that type 7 vaccine is expected to witness higher growth over the forecast period due to its affordability and ability to instantly confer immunity.

North America is expected to witness highest growth over the forecast period due to due to the high prevalence of adenovirus infection and continuous population growth in the region.

Features of the Global Adenovirus Vaccine Market

Market Size Estimates: Adenovirus vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Adenovirus vaccine market size by type, application, and region in terms of value ($B).

Regional Analysis: Adenovirus vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the adenovirus vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the adenovirus vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the adenovirus vaccine market size?

Answer: The global adenovirus vaccine market is expected to reach an estimated $1.4 billion by 2030.

Q.2 What is the growth forecast for adenovirus vaccine market?

Answer: The global adenovirus vaccine market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the adenovirus vaccine market?

Answer: The major drivers for this market are the rapidly increasing need for vaccinations in cancer gene therapies and surge in vaccination demand from pharmaceutical companies.

Q4. What are the major segments for adenovirus vaccine market?

Answer: The future of the adenovirus vaccine market looks promising with opportunities in the research and academic, laboratories, and pharmaceutical & biotechnology markets.

Q5. Who are the key adenovirus vaccine market companies?

Answer: Some of the key adenovirus vaccine companies are as follows:

• Novasep
• Charles River Laboratories
• Uniqure
• Waisman Biomanufacturing
• Creative-Biogene
• Aldevron
• Addgene
• Thermo Fisher Scientific
• Fujifilm Corporation
• Spark Therapeutics

Q6. Which adenovirus vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that type 7 vaccine is expected to witness higher growth over the forecast period due to its affordability and ability to instantly confer immunity.

Q7. In adenovirus vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to due to the high prevalence of adenovirus infection and continuous population growth in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the adenovirus vaccine market by type (type 4 vaccine and type 7 vaccine), application (research and academic, laboratories, and pharmaceutical & biotechnology), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?